🇺🇸 FDA
Patent

US 10351844

Methods and compositions for treating leber congenital amaurosis

granted A61KA61K31/7088A61K48/00

Quick answer

US patent 10351844 (Methods and compositions for treating leber congenital amaurosis) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/7088, A61K48/00, A61K48/005, A61P